Citing the possibility of another serious pandemic, the Biden administration on Friday laid out a plan to transform the nation’s ability to respond to major biological threats.
As staggering as the COVID-19 pandemic has been, the next one will likely be very different – and could be far worse, officials warn.
“We need better capabilities,” said Eric Lander, director of the White House Office of Science & Technology Policy, “because there’s a reasonable likelihood that another serious pandemic that could be worse than COVID-19 will occur soon and possibly even within the next decade.”
Lander compared the administration’s $65.3 billion proposal to the scope and seriousness of the Apollo Program, created to put a man on the moon. More than one-third of the cost would be spent on vaccine development and distribution capabilities.
Lander said the administration is optimistic that lawmakers will include an initial $15 billion in the $3.5 trillion spending package that Democrats hope to pass this fall to expand the social safety net, address climate change and more.
While continuing to fight the coronavirus pandemic, officials said the nation needs to be better prepared for biological threats, whether they’re naturally occurring diseases, laboratory accidents or deliberate acts of bio-warfare.
“We thought it was urgent to get started on this immediately,” said Beth Cameron, the National Security Council senior director for global health and biodefense.
The plan includes:
- Dramatically expanding the arsenal of vaccines, therapeutics and diagnostics.
- Strengthening public health systems both in the U.S. and internationally.
- Improving the ability of the U.S. to produce personal protective equipment and other vital supplies.
- Improving early detection of pandemic threats.
- Creating a centralized “mission control” to be in charge of an effort that will draw on multiple federal agencies.
Lander said the nation must prepare not only for the increasing frequency of biological threats by increasing stockpiles but must also improve the science and technology to respond.
“Five years from now, we need to have much better capabilities,” he said.
In a future pandemic, for example, people shouldn’t have to drive to a CVS to get tested. Tests could be cheaper and more convenient, including the ability to frequently take them at home.
Those improvements could pay dividends beyond pandemic preparedness, Lander said. They could also improve public health generally.
Within a day of testing positive for covid-19 in June, Miranda Kelly was sick enough to be scared. At 44, with diabetes and high blood pressure, Kelly, a certified nursing assistant, was having trouble [...]
A technology developed at Vanderbilt University Medical Center has led to the discovery of an "ultra-potent" monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant. The antibody [...]
Research has found a significant fall in levels of antibodies against SARS-CoV-2, the virus that causes COVID-19, 6 months after the second dose of the Pfizer-BioNTech vaccine. Clinical evidence also suggests that the risk [...]
Are the COVID vaccines substantially different from/inferior to other vaccines in terms of their effectiveness? The issue raised, and I'm mostly paraphrasing here, is this: Most vaccines (e.g. measles, smallpox) have efficacy defined such [...]
The EVONANO platform allows scientists to grow virtual tumors and use artificial intelligence to automatically optimize the design of nanoparticles to treat them. The ability to grow and treat virtual tumors is an [...]
Modern Approaches to Augmentation of Brain Function Available from Springer Press This book covers recent advances in neural technology that provide for enhancements for brain function. It addresses a broad range of neural phenomena [...]
Although the currently available COVID-19 vaccines are highly effective, limited manufacturing capacity and the need for cold-chain storage hinder their global distribution. A recent study tested the efficacy of a new adeno-associated virus (AAV) [...]
Fully vaccinated people were 11 times less likely to die of COVID and 10 times less likely to be hospitalized compared to the unvaccinated since highly contagious Delta became the most common variant, US [...]
The highly-infectious Delta coronavirus variant has spread to at least 174 countries worldwide, from the US to Australia, causing a surge in COVID-19 cases. The variant has mutations that help it partially escape the immune response produced by [...]
Fragile mRNA molecules used in COVID-19 vaccines can’t get into cells on their own. They owe their success to lipid nanoparticles that took decades to refine. Messenger RNA (mRNA) is having a moment. This [...]
The COVID-19 pandemic has revealed critical knowledge gaps and assumptions concerning how respiratory viruses spread between hosts. Traditionally thought to be spread mainly through large respiratory droplets produced by the coughs and sneezes of sick individuals, [...]
SARS-CoV-2 is just one of nonillions of viruses on our planet, and scientists are rapidly identifying legions of new species. Mya Breitbart has hunted novel viruses in African termite mounds, Antarctic seals and water [...]
As a team of South African researchers we have identified a new lineage of SARS-CoV-2, the virus causing COVID-19. A lineage represents a genetically distinct virus population with a common ancestor. This virus may be designated as a variant [...]